Which cardiomyopathies can be characterized using cardiac magnetic resonance imaging (MRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cardiac MRI Characterizes a Comprehensive Range of Cardiomyopathies

Cardiac MRI can characterize virtually all major cardiomyopathy subtypes through its superior tissue characterization capabilities, including hypertrophic, dilated, restrictive, arrhythmogenic, non-compaction, stress-induced (Takotsubo), peripartum, muscular dystrophy-related, and infiltrative cardiomyopathies (amyloidosis, sarcoidosis, Anderson-Fabry disease, hemochromatosis). 1

Primary Cardiomyopathies Characterized by Cardiac MRI

Hypertrophic Cardiomyopathy (HCM)

  • Morphological assessment: MRI excels at identifying all phenotypic variants (asymmetric septal, apical, mid-ventricular, lateral wall, mass-like, and concentric types) 1
  • Superior visualization: Detects areas missed by echocardiography, particularly the LV apex, LV lateral wall, LV basal septum, and RV 1
  • Late gadolinium enhancement (LGE): Present in 50-80% of HCM patients; extent >15% of LV mass predicts sudden cardiac death risk 1
  • Distinguishes phenocopies: Differentiates true HCM from Anderson-Fabry disease (shows low native T1 values from sphingolipid deposition with basal inferolateral LGE), Danon disease, athlete's heart, and hypertensive heart disease 1

Dilated Cardiomyopathy (DCM)

  • Functional quantification: Provides gold-standard measurements of LV/RV volumes, mass, and ejection fraction with high reproducibility 1, 2
  • LGE patterns: Linear mid-myocardial or patchy patterns help distinguish etiology and predict malignant arrhythmia risk 1
  • Parametric mapping: T1-mapping and extracellular volume (ECV) quantification detect early fibrosis and track therapeutic response 1
  • Strain imaging: Detects regional dysfunction in early disease stages before overt heart failure 2

Restrictive Cardiomyopathies

Cardiac Amyloidosis:

  • Characteristic finding: Early unusual contrast washout with subendocardial enhancement and non-suppressible remote myocardium signal 3
  • Elevated ECV and T1 values: Quantifies amyloid burden
  • Differentiates from constrictive pericarditis: Unlike constrictive pericarditis, amyloidosis shows normal pericardial thickness 3

Anderson-Fabry Disease:

  • Pathognomonic feature: Low native T1 values (from sphingolipid deposition) before structural abnormalities develop 1
  • LGE pattern: Mid-myocardial or subepicardial in basal inferolateral LV segment 1

Hemochromatosis:

  • T2 mapping*: Detects and quantifies iron overload with high sensitivity 1

Sarcoidosis:

  • Patchy mid-myocardial or subepicardial LGE: Indicates granulomatous inflammation
  • T2-weighted imaging: Detects active myocardial edema 1

Arrhythmogenic Cardiomyopathy (AC)

  • Structural abnormalities: Superior detection of RV wall thinning, aneurysms in the "triangle of dysplasia" (inferior, apical, infundibular walls) 4
  • Fatty infiltration and fibrosis: Distinguishes pathological fatty replacement from normal epicardial fat 4
  • LV involvement: Detects posterolateral LV involvement in >50% of cases, often missed by other modalities 4
  • Quantitative parameters: RV volumes, ejection fraction, and regional wall motion abnormalities for diagnostic criteria 4

Left Ventricular Non-Compaction (LVNC)

  • Diagnostic criteria: Non-compacted to compacted myocardial thickness ratio >2.3 in end-diastole 1
  • Additional metrics: Trabecular mass >15 g/m², trabecular-to-total LV mass ratio >20-25% 1
  • Prognostic value: Higher ratios and presence of LGE predict heart failure and arrhythmia development 1
  • Caveat: 15-43% of asymptomatic healthy individuals meet current MRI criteria, suggesting poor specificity—may represent anatomical variant rather than true cardiomyopathy 1

Stress-Induced (Takotsubo) Cardiomyopathy

  • Morphological pattern: LV apical ballooning with hyperkinetic basal segments (also reverse and mid-ventricular variants) 1
  • Myocardial edema: High T2 signal, elevated native T1 and T2 values in affected segments 1
  • LGE findings: Typically absent, but present in up to 40% with lower signal intensity (<5 SD above normal) indicating worse prognosis 1
  • RV involvement: Detected in 40% of cases, associated with worse prognosis 1

Peripartum Cardiomyopathy

  • Functional assessment: LV dilation, global LV systolic dysfunction, RV dysfunction 1
  • LGE pattern: Subepicardial or mid-myocardial in anterior/anterolateral segments (40% of cases), more common >7 days post-acute phase 1
  • Prognostic marker: Presence of LGE predicts failure to regain LVEF and higher decompensation rates 1

Muscular Dystrophies

  • Early detection: LGE may be present when echocardiography remains normal 1
  • Pattern: Mid-myocardial/subepicardial LGE, occasional non-compacted myocardium 1
  • Monitoring: Strain imaging detects abnormalities before overt heart failure and tracks disease progression 1
  • T1/ECV abnormalities: Associated with arrhythmia risk 1

Key MRI Sequences and Their Applications

Late Gadolinium Enhancement (LGE)

  • Universal prognostic value: Regardless of etiology, extent of LGE predicts malignant arrhythmia and heart failure risk 1
  • Pattern recognition: Different LGE distributions distinguish cardiomyopathy subtypes:
    • Linear mid-myocardial: DCM
    • Patchy mid-myocardial: Myocarditis, sarcoidosis
    • Subepicardial: Myocarditis
    • Subendocardial: Amyloidosis, ischemia
    • Basal inferolateral: Anderson-Fabry disease 1

Parametric Mapping

  • T1-mapping: Detects diffuse fibrosis, edema, and infiltration without contrast (useful in renal dysfunction) 1
  • T2-mapping: Identifies inflammatory processes with high sensitivity 1
  • T2-mapping*: Quantifies iron overload in hemochromatosis 1
  • ECV quantification: Increased in multiple disorders; tracks therapeutic response more sensitively than LGE 1

Functional Imaging

  • Cine sequences: Evaluate morphology (thickening, thinning, apical ballooning, trabeculations) and quantify function with high reproducibility 1
  • Strain imaging: Detects early regional dysfunction before global systolic impairment 1, 2
  • Stress perfusion: Excludes ischemia and detects microvascular dysfunction 1

Clinical Advantages Over Other Modalities

Superior to echocardiography for:

  • Visualizing LV apex, lateral wall, basal septum, and entire RV 1
  • Quantifying myocardial thickness accurately (critical for HCM surgical planning) 1
  • Assessing non-compaction extent in all LV segments 1
  • Detecting subtle structural changes in early disease 2

Complementary to cardiac CT:

  • Higher contrast-to-noise ratio for tissue characterization 1
  • No radiation exposure, allowing serial follow-up 1
  • Superior temporal resolution for functional assessment 2

Important Clinical Caveats

  1. Device compatibility: MRI can now be performed on most pacemakers/ICDs with technical adjustments and wide-band inversion recovery sequences to mitigate artifacts 1

  2. Contrast considerations: Native T1-mapping enables tissue characterization without gadolinium in patients with renal dysfunction 1

  3. Vendor variability: Use same vendor for serial surveillance when assessing strain parameters 2

  4. LVNC overdiagnosis: Current MRI criteria have poor specificity (15-43% false positives in healthy individuals)—integrate clinical context 1

  5. Endomyocardial biopsy guidance: MRI can direct biopsy to areas of active inflammation or fibrosis 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.